Liposomes as nanomedical devices

G Bozzuto, A Molinari - International journal of nanomedicine, 2015 - Taylor & Francis
Since their discovery in the 1960s, liposomes have been studied in depth, and they continue
to constitute a field of intense research. Liposomes are valued for their biological and …

New developments in liposomal drug delivery

BS Pattni, VV Chupin, VP Torchilin - Chemical reviews, 2015 - ACS Publications
New Developments in Liposomal Drug Delivery | Chemical Reviews ACS ACS Publications
C&EN CAS Find my institution Log In Chemical Reviews ACS Publications. Most Trusted. Most …

Therapeutic applications of nanobiotechnology

Y Dutt, RP Pandey, M Dutt, A Gupta, A Vibhuti… - Journal of …, 2023 - Springer
Nanobiotechnology, as a novel and more specialized branch of science, has provided a
number of nanostructures such as nanoparticles, by utilizing the methods, techniques, and …

pH-responsive, adorned nanoniosomes for codelivery of cisplatin and epirubicin: synergistic treatment of breast cancer

A Moammeri, K Abbaspour, A Zafarian… - ACS applied bio …, 2022 - ACS Publications
Combination chemotherapy has become a treatment modality for breast cancer. However,
serious side effects and high cytotoxicity associated with this combination therapy make it a …

[HTML][HTML] Development of liposomal formulations: From concept to clinical investigations

Y Fan, Q Zhang - Asian journal of pharmaceutical sciences, 2013 - Elsevier
Liposome is one of the most successful drug delivery systems applying nanotechnology to
potentiate the therapeutic efficacy and reduce toxicities of conventional medicines. Since the …

Current understandings and clinical translation of nanomedicines for breast cancer therapy

Y Jiang, Z Jiang, M Wang, L Ma - Advanced drug delivery reviews, 2022 - Elsevier
Breast cancer is one of the most frequently diagnosed cancers that is threatening women's
life. Current clinical treatment regimens for breast cancer often involve neoadjuvant and …

The latest advances of cisplatin liposomal formulations: essentials for preparation and analysis

F Zahednezhad, P Zakeri-Milani… - Expert opinion on …, 2020 - Taylor & Francis
Introduction: Cisplatin has been indicated for several malignancies all over the world for
many years. Increasing patient tolerance for high dose of chemotherapeutics and reducing …

Liposomal delivery systems and their applications against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus

JC Nwabuife, AM Pant, T Govender - Advanced Drug Delivery Reviews, 2021 - Elsevier
Liposomal delivery systems have been widely explored for targeting superbugs such as S.
aureus and MRSA, overcoming antimicrobial resistance associated with conventional …

A combination RNAi-chemotherapy layer-by-layer nanoparticle for systemic targeting of KRAS/P53 with cisplatin to treat non–small cell lung cancer

L Gu, ZJ Deng, S Roy, PT Hammond - Clinical cancer research, 2017 - AACR
Abstract Purpose: Mutation of the Kirsten ras sarcoma viral oncogene homolog (KRAS) and
loss of p53 function are commonly seen in patients with non–small cell lung cancer …

Effectiveness of an adjuvant chemotherapy regimen for early-stage breast cancer: a systematic review and network meta-analysis

T Fujii, F Le Du, L Xiao, T Kogawa, CH Barcenas… - JAMA …, 2015 - jamanetwork.com
Importance Different adjuvant chemotherapy regimens are available for early-stage breast
cancer. Because conventional meta-analysis does not allow comparing all regimens, we …